Search
for
Sort by
Research 691–720 of 1000+
- Telocytes in human skin – are they involved in skin regeneration?
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- What do we know about phytotherapy of benign prostatic hyperplasia?
- HRT for women with premature ovarian insufficiency: a comprehensive review
- JAK inhibitors and alopecia areata
- Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Toward a Diagnostic Score in Cushing's Syndrome
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations
- Oral Minoxidil in the Treatment of Hypertensive Crisis
- Optimization of LC method for the determination of testosterone and epitestosterone in urine samples in view of biomedical studies and anti-doping research studies
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia